Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.15 EUR
Change Today 0.00 / 0.00%
Volume 0.0
As of 6:05 AM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

lavipharm s.a. (BXA) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/24/15 - €0.17
52 Week Low
12/15/14 - €0.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LAVIPHARM S.A. (BXA)

Related News

No related news articles were found.

lavipharm s.a. (BXA) Related Businessweek News

No Related Businessweek News Found

lavipharm s.a. (BXA) Details

Lavipharm S.A. develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products in Greece and internationally. The company primarily offers a range of pharmaceutical products in the areas of cardiology, chronic pain and oncology, central nervous system, general medicine and respiratory system, gastrointestinal system, and urology. It also provides over the counter antiseptics, analgesics, gynecology, anti-lice treatment, and natural products; and dermocosmetics, such as skincare products. In addition, the company offers Trinipatch, a nitroglycerine transdermal delivery system used for the prevention of angina. Its product pipeline includes nicotine transdermal system for smoking cessation; various OTC products for the symptoms of common cold, oral hygiene, and excessive excretion of shawl; and food supplements. The company primarily serves health professionals, physicians, and pharmacists. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece.

Founded in 1911

lavipharm s.a. (BXA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BXA:GR €0.15 EUR 0.00

BXA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BXA.
View Industry Companies

Industry Analysis


Industry Average

Valuation BXA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LAVIPHARM S.A., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at